High blood cholesterol and triglycerides and Labyrinthine fistula

Summary:

Labyrinthine fistula is reported only by a few people with High blood cholesterol and triglycerides.

The study analyzes which people have Labyrinthine fistula with High blood cholesterol and triglycerides. It is created by eHealthMe based on 3 people who have Labyrinthine fistula and High blood cholesterol and triglycerides from the Food and Drug Administration (FDA), and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Jun, 10, 2023

3 people who have High Blood Cholesterol And Triglycerides and Labyrinthine Fistula are studied.


What is High blood cholesterol and triglycerides?

High blood cholesterol and triglycerides is found to be associated with 3,592 drugs and 3,514 conditions by eHealthMe.

What is Labyrinthine fistula?

Labyrinthine fistula (an abnormal opening in the bony capsule of the inner ear) is found to be associated with 66 drugs and 92 conditions by eHealthMe.

Number of Labyrinthine fistula in High blood cholesterol and triglycerides reports submitted per year:

Would you have Labyrinthine fistula when you have High blood cholesterol and triglycerides?

Gender of people who have High Blood Cholesterol And Triglycerides and experienced Labyrinthine Fistula *:

  • female: 0.0 %
  • male: 100 %

Age of people who have High Blood Cholesterol And Triglycerides and experienced Labyrinthine Fistula *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 100 %
  • 60+: 0.0 %

Common co-existing conditions for these people *:

  1. Weight Loss: 2 people, 66.67%
  2. Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 2 people, 66.67%
  3. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 66.67%
  4. Type 2 Diabetes: 1 person, 33.33%
  5. Stress And Anxiety: 1 person, 33.33%
  6. Nervous System Disorder (a general class of medical conditions affecting the nervous system): 1 person, 33.33%
  7. Depression: 1 person, 33.33%

Common drugs taken by these people *:

  1. Trilipix: 2 people, 66.67%
  2. Simvastatin: 2 people, 66.67%
  3. Rebif: 2 people, 66.67%
  4. Aspirin: 2 people, 66.67%
  5. Zoloft: 1 person, 33.33%
  6. Verapamil Hcl: 1 person, 33.33%
  7. Metformin: 1 person, 33.33%
  8. Lopid: 1 person, 33.33%
  9. Klonopin: 1 person, 33.33%

Common symptoms for these people *:

  1. Blood Testosterone Decreased: 2 people, 66.67%
  2. Drug Ineffective: 1 person, 33.33%
  3. Blood Glucose Increased: 1 person, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Labyrinthine fistula?

Check whether Labyrinthine fistula is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Labyrinthine fistula:

All the drugs that are associated with Labyrinthine fistula:

All the conditions that are associated with Labyrinthine fistula:

How the study uses the data?

The study is based on Labyrinthine fistula and High blood cholesterol and triglycerides, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: